110651-92-8Relevant articles and documents
TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS
-
, (2014/05/08)
The present invention provides tricyclic fused thiophene derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
1H-IMIDAZO[4,5-D]THIENO[3,2-B]PYRIDINE BASED TRICYCLC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
-
Page/Page column 28-29, (2008/06/13)
-